Previous studies suggest that oxytocin is negatively associated with depression and anxiety in chronic pain patients [53] and depressive disorder patients [54], where administration of oxytocin has been shown to reduce activation of the amygdala for negative stimuli [55]. Here, OXT is linked to depressive symptom measurement.